Evox Therapeutics raises $45 million for exosome therapies
Wednesday, September 5, 2018 - 16:00
in Biology & Nature
Oxford spin-off’s lead program aims to treat a lysosomal storage disorder by crossing the blood-brain barrier
Updated by artificial intelligence Thu, 13 Mar 2025, 3:35:01 UTC Learn more
- Tell your friends
- Get science news via